Diagnostic Cartridge Field Diagnostic System Market Analysis

  • Report ID: 3936
  • Published Date: Jul 26, 2024
  • Report Format: PDF, PPT

Diagnostic Cartridge Field Diagnostic System Market Analysis

Type (Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Electrolytes Testing)

The cardiac markers testing segment is slated to hold 40% share of the global diagnostic cartridge field diagnostic system market by 2036. The increasing cases of myocardial infarction (MI), commonly known as a heart attack can be predicted earlier with cardiac marker tests that identify blood chemicals associated with myocardial infarction. As per findings, in the United States, nearly at every 40 seconds someone suffers from a heart attack.

End-User (Specialty Clinics, Laboratory, Hospitals)

The hospital segment is anticipated to account for around 40% revenue share by 2036, owing to the rising advancements in diagnostic activities in the hospital setting. Increasing the use of handheld/ portable diagnostics devices is also propelling the market growth.

Further, healthcare practitioners also collect a blood sample from the patient and send this sample to a satellite lab for quick results due to the increasing volume of diagnoses that need to be performed in hospitals.

Our in-depth analysis of the global market includes the following segments:

  Type

  • Infectious Diseases Testing
  • Cardiac Markers Testing
  • Coagulation Testing
  • Electrolytes Testing

  End User

  • Specialty Clinics
  • Laboratory
  • Hospitals
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3936
  • Published Date: Jul 26, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of diagnostic cartridge field diagnostic system is assessed at USD 7.66 Billion.

The diagnostic cartridge field diagnostic system market size was over USD 7.34 Billion in 2023 and is expected to reach USD 13.49 Billion by the end of 2036, witnessing around 4.8% CAGR during the forecast period i.e., between 2024-2036. The increasing prevalence of chronic and acute diseases is anticipated to be major growth drivers of the market.

Asia Pacific region is likely to hold 35% industry share by 2036, led by increasing spread of disease in the region is resulting in several collaborations between corporates and multinational companies to uplift the overall diagnostic market.

Siemens Healthineers AG, Abbott Laboratories, F. Hoffmann-La Roche AG, Danaher Corporation, Bio-Rad Laboratories, Inc., Sysmex Corporation, Arkray Inc., Becton, Dickinson, and Company, Binx Health Limited, Nova Biomedical Corporation
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample